Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Advocacy in a COVID-19 America

Ellen M. Gravallese, MD  |  Issue: June 2020  |  June 15, 2020

Talking Points

This year, these important meetings focused on the many challenges practices and patients are facing in the new reality of life during the COVID-19 pandemic. Advocates discussed issues affecting patient access to care, including maintaining provider solvency so rheuma­tologists and rheumatology interprofessional team members can continue to care for the estimated 91 million Americans suffering from rheumatic disease.

Advocates highlighted the fact that a shortage of rheumatologists existed pre-COVID-19 and patients have already had difficulty accessing rheumatologic care.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

They discussed provider solvency as a key issue during the pandemic, making it clear that practices are financially challenged due to the need for social distancing for patients, decreasing the number of patients seen and often requiring extended office hours to enhance patient safety. In addition, costs incurred for overtime payments and for the purchase of additional personal protective equipment increase the concern that practices may lose the ability to continue to provide adequate payment to staff.

Advocacy for the rheumatology community continues in these challenging times, & I hope you will add your voice as we continue this journey together.

Recognizing that many rheumatology providers and practices are suffering financially, advocates asked that additional financial assistance to providers to be included in the next Congressional package for COVID-19 relief. Although the funds designated for practices and institutions in the CARES Act were immensely helpful, these funds will clearly be inadequate to ensure patient access and provider solvency through the duration of the pandemic.

Hill offices were encouraged to press for the passage of healthcare provider-specific grant and loan programs, and support the American Medical Association’s request for an emergency, one-time grant for providers equal to their total payroll and overhead costs from Jan. 1–April 1, 2019.

For employed physicians, advocates also discussed the need for funds to be specif­ically directed to maintain provider and staff salaries, to prevent further job losses, furloughs and salary cuts.

Other advocacy issues raised with legislators included asking for universal parity for reimbursement of audio-only and audiovisual telehealth, and continued support for the evaluation and management (E/M) payment improvements set to go into effect in January 2021.

Offices on Capitol Hill heard from rheumatology advocates about their experiences with telehealth during the pandemic and the crucial need for flexibility in telehealth options to maintain access for patients. Rheumatology practices are relying on traditional telehealth, as well as telephone visits, to treat patients safely while in-person evaluation and treatment may be restricted.

A few months ago, we saw the Centers for Medicare & Medicare Services (CMS) respond to our advocacy efforts by acknowledging the importance of this access, including reimbursement for not only audiovisual telehealth, but also audio-only telephone visits for those patients who may not have access to the necessary technology to allow for traditional audiovisual visits. Lawmakers were asked to request the CMS have Medicare Administrative Contractors (MACs) issue blanket adjustments of payments for all audio-only CMS claims back to March 1, so individual providers don’t have to take time away from patient care to do the arduous resubmission of claims already filed.

Advocates also promoted H.R. 6644, the Healthcare at Home Act, which would have employer-based health plans also expand parity in reimbursement to audio-only telehealth visits, following the lead of the CMS.

Finally, advocates discussed the importance of the updates to E/M coding, finalized by the CMS and scheduled to go into effect in January 2021. These updates are estimated to result in an average 15% raise in pay, an important win for rheumatologists. These improvements are critical to ensure an adequate workforce of providers treating rheumatic diseases and the chronic illnesses that often ensue in our patients most in need of care.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & AdvocacyPresident's PerspectiveTechnology Tagged with:COVID-19RheumPAC

Related Articles

    Telerheumatology: What’s Next?

    December 17, 2020

    In an ACR Convergence session, two rheumatologists discussed how COVID-19 changed the use of telemedicine, how payers reacted and which changes are likely permanent and which are likely to be temporary.

    Telehealth Brings Opportunities to Enhance Patient Care

    December 8, 2022

    During an ACR webinar in August, presenters discussed multiple aspects of telehealth in rheumatology, especially related to rheumatology fellowship training. They agreed that although telehealth represents one potential avenue to improve patient access to treatment for rheumatic disease, we must keep identifying the best ways to employ telehealth to enhance care. Impact of Pandemic Telemedicine…

    What’s Next for Telehealth after the COVID-19 Public Health Emergency?

    June 10, 2023

    Do you remember where you were when the COVID-19 Public Health Emergency (PHE) was declared on Jan. 31, 2020? While it may seem like yesterday, you would be forgiven for not recalling your exact location over three years ago during what felt like an incredible whirlwind for the healthcare industry. One possible location you may…

    Providers & Patients Talk to Legislators about Telehealth, Workforce Shortage

    September 18, 2020

    On Sept. 15, rheumatology advocates met virtually with members of Congress to share personal accounts of how telehealth is making a difference during the COVID-19 pandemic and what will help stem a workforce shortage.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences